Orexin deficiency affects sensorimotor gating and its amphetamine-induced impairment

Area of Science:

• Neuroscience
• Behavioral Science
• Psychiatry

Background:

• Orexin neuropeptides regulate sleep-wake cycles, foraging, reward, and emotions.
• The orexin system is implicated in neuropsychiatric disorders, including social avoidance and cognitive inflexibility.
• Sensorimotor gating and amphetamine sensitivity are relevant behavioral endophenotypes in neuropsychiatric disorders.

Purpose of the Study:

• To investigate the role of orexin in sensorimotor gating.
• To determine orexin's involvement in amphetamine sensitivity.
• To explore orexin's contribution to behavioral endophenotypes of neuropsychiatric disorders.

Main Methods:

• Utilized orexin-deficient mice (homozygous and heterozygous) and wildtype controls.
• Assessed sensorimotor gating using prepulse inhibition of the startle response.
• Administered amphetamine and measured its effects on sensorimotor gating, locomotor activity, and open field behavior.

Main Results:

• Orexin-deficient mice exhibited a significant deficit in sensorimotor gating (prepulse inhibition).
• Amphetamine impaired prepulse inhibition in wildtype and heterozygous mice but not in homozygous orexin-deficient mice.
• Orexin deficiency did not affect baseline locomotor activity or open field behavior, nor did it alter amphetamine's effects on these measures.

Conclusions:

• The orexin system modulates sensorimotor gating.
• Orexin is involved in mediating the effects of amphetamine on sensorimotor gating.
• Pharmacological targeting of the orexin system may offer therapeutic potential for neuropsychiatric conditions with sensorimotor gating deficits, such as schizophrenia and ADHD.